IDEAYA Biosciences to Participate in Investor Conferences in November 2021

/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality focused precision medicine oncology company committed to the discovery and...

Related Keywords

Tim Chiang ,Yujiro Hata ,Biosciences Inc ,Exchange Commission ,Panel Discussion New Advances In Synthetic Lethality ,Company Presentation ,Equity Research Analyst ,Nasdaq ,Chief Executive Officer ,Managing Director ,Senior Analyst ,Chief Scientific Officer ,Ideaya Biosciences ,Nc ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,